1,137
Views
0
CrossRef citations to date
0
Altmetric
Licensed Vaccines – Research Article

A phase I, open label, clinical study to assess the safety and immunogenicity of indigenously developed liquid (DTwP-HepB-IPV-Hib) hexavalent combination vaccine in healthy toddlers aged 16–24 months

, , , , , , , , , , & show all
Article: 2146435 | Received 26 Aug 2022, Accepted 08 Nov 2022, Published online: 22 Nov 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.